INTERNATIONAL PATENT: SINGH BIOTECHNOLOGY, LLC, THE UNITED STATES OF AMERICA, AS RESPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES FILES APPLICATION FOR "SUPPRESSION OF NEURODEGENERATIVE DISEASES BY SINGLE DOMAIN ANTIBODY"

GENEVA, Dec. 22 -- SINGH BIOTECHNOLOGY, LLC (1170 Gulf Blvd., Apt #605Clearwater, Florida 33767), THE UNITED STATES OF AMERICA, AS RESPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Office of Technology Transfer, NIH6701 Rockledge Drive, Suite 700, MSC 7788Bethesda, Maryland 20892-7788) filed a patent application (PCT/IB2025/056102) for "SUPPRESSION OF NEURODEGENERATIVE DISEASES BY SINGLE DOMAIN ANTIBODY" on Jun 13, 2025. With publication no. WO/2025/257810, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor...